Q4 2023 Scandion Oncology A/S Earnings Call Transcript
Welcome to Scandion Oncology Q4 report 2023. (Operator Instructions)
Now I will hand the conference over to CEO, Francois Martelet; and CFO, Johnny Stilou. Please go ahead.
/-
Thank you very much, and good morning to everyone, and welcome to our quarterly four year-end report for 2023. As you heard, my name is Francois Martelet. I'm the CEO of Scandion Oncology. With me today is our Chief Financial Officer, Johnny Stilou. We will be updating you on the development and financial results from the fourth quarter of '23, as well as recent events as well. Following our presentation, we will be pleased to answer any questions you may have.
Please be informed that to best address your questions, we ask you to state this verbally. It would not be possible to put questions forward in writing, so if you have a question, please follow the operator instructions and ask verbally. Please note that you will have to dial in to the call to be able to ask a question. This cannot be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |